KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Rega Institute, Leuven, Belgium.
Nat Genet. 2021 Apr;53(4):435-444. doi: 10.1038/s41588-021-00805-2. Epub 2021 Mar 8.
The ongoing COVID-19 pandemic has caused a global economic and health crisis. To identify host factors essential for coronavirus infection, we performed genome-wide functional genetic screens with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human coronavirus 229E. These screens uncovered virus-specific as well as shared host factors, including TMEM41B and PI3K type 3. We discovered that SARS-CoV-2 requires the lysosomal protein TMEM106B to infect human cell lines and primary lung cells. TMEM106B overexpression enhanced SARS-CoV-2 infection as well as pseudovirus infection, suggesting a role in viral entry. Furthermore, single-cell RNA-sequencing of airway cells from patients with COVID-19 demonstrated that TMEM106B expression correlates with SARS-CoV-2 infection. The present study uncovered a collection of coronavirus host factors that may be exploited to develop drugs against SARS-CoV-2 infection or future zoonotic coronavirus outbreaks.
持续的 COVID-19 大流行造成了全球经济和健康危机。为了确定冠状病毒感染所必需的宿主因素,我们使用严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和人类冠状病毒 229E 进行了全基因组功能遗传筛选。这些筛选揭示了病毒特异性和共同的宿主因素,包括 TMEM41B 和 PI3K 类型 3。我们发现 SARS-CoV-2 需要溶酶体蛋白 TMEM106B 才能感染人细胞系和原代肺细胞。TMEM106B 的过表达增强了 SARS-CoV-2 的感染和假病毒感染,表明其在病毒进入中起作用。此外,对 COVID-19 患者气道细胞的单细胞 RNA 测序表明,TMEM106B 的表达与 SARS-CoV-2 感染相关。本研究揭示了一组冠状病毒宿主因素,这些因素可能被用来开发针对 SARS-CoV-2 感染或未来动物源性冠状病毒爆发的药物。